| Breakdown | TTM | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.94M | 3.84M | 3.83M | 3.08M | 2.97M | 2.26M |
| Gross Profit | 3.75M | 3.84M | 3.83M | 3.08M | 2.97M | 2.26M |
| EBITDA | 201.00K | 479.00K | 660.00K | 408.00K | 370.00K | -539.00K |
| Net Income | 101.00K | 153.00K | 282.00K | 233.00K | 152.00K | -688.00K |
Balance Sheet | ||||||
| Total Assets | 5.16M | 6.13M | 6.26M | 5.51M | 6.19M | 4.96M |
| Cash, Cash Equivalents and Short-Term Investments | 3.48M | 4.21M | 3.83M | 2.75M | 3.37M | 2.89M |
| Total Debt | 130.00K | 231.00K | 312.00K | 427.00K | 1.01M | 577.00K |
| Total Liabilities | 919.00K | 1.67M | 1.82M | 1.33M | 2.16M | 1.58M |
| Stockholders Equity | 4.24M | 4.46M | 4.44M | 4.18M | 4.03M | 3.38M |
Cash Flow | ||||||
| Free Cash Flow | -20.00K | 576.00K | 684.00K | 45.00K | -30.00K | -688.00K |
| Operating Cash Flow | -5.00K | 580.00K | 698.00K | 50.00K | 322.00K | -688.00K |
| Investing Cash Flow | 2.94M | 2.62M | -434.00K | -5.00K | -334.00K | 2.00K |
| Financing Cash Flow | -334.00K | -321.00K | -205.00K | -655.00K | 485.00K | -46.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £22.59M | 11.12 | 24.60% | 7.10% | 7.02% | -12.85% | |
73 Outperform | £281.15M | 17.20 | 10.86% | 3.66% | 97.27% | 25.80% | |
69 Neutral | £133.14M | 13.93 | 8.96% | 2.05% | 10.84% | 113.75% | |
66 Neutral | £3.59M | 935.51 | 2.37% | 6.43% | -6.18% | -66.67% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | £220.30M | 15.87 | 19.04% | 3.59% | 20.46% | ― | |
54 Neutral | £1.16B | 19.15 | 9.70% | 2.20% | 7.81% | 22.76% |